The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against using testosterone treatment in healthy girls. Although the FDA approved testosterone therapy for the treatment of diseases involving the testes, pituitary and hypothalamus, it has not been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the security of testosterone. The study included approximately 800 elderly men with low testosterone
and symptoms associated with this ailment, including http://tinyurl.com/jkhvqy9
sexual and physical dysfunction. The research is anticipated to shed more light on the security of testosterone treatment since the heart health of the men was carefully monitored.
The recent contradictory findings on testosterone therapy prompted his team to conduct a sizeable systematic literature search for studies evaluating the relationship between testosterone replacement therapy and cardiovascular events among guys and Patel. An estimated 13 million men in the United States suffer with low testosterone, which occurs when the body doesn't make enough hormones as a result of a difficulty with the testicles or pituitary gland. This explains decline of energy, apparent aging and an individual's sudden weight gain.
And many girls have a knee jerk suspicion that any hormone treatment can increase their risk of breast cancer. Nevertheless, clinical studies show that testosterone not only does not increase a woman's risk of breast cancer , it may play a key role in warding off the disease. Glaser thinks this will likely remain the status quo for some time, given the prohibitive cost of running the long term safety studies needed to gain more total FDA approval.